13 August 2021
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021 (Revised)
11 August 2021
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021
11 August 2021
Financial Performance Quarter 2 (F45) (Reviewed)
11 August 2021
Financial Statement Quarter 2/2021 (Reviewed)
21 July 2021
Report on use of proceeds from capital increase raised from IPO
13 May 2021
Dissemination of the Minutes of the 2021 Annual General Meeting of Shareholders
12 May 2021
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2021
12 May 2021
Financial Performance Quarter 1 (F45) (Reviewed)
12 May 2021
Financial Statement Quarter 1/2021 (Reviewed)
05 May 2021
Notification of MOU on develop products containing hemp
27 April 2021
Appointment Directors
27 April 2021
Shareholders meeting's resolution
29 March 2021
Publication of the Invitation Letter to the 2021 Annual General Meeting
24 February 2021
Dividend Payment, 2021 Annual General Meeting of Shareholders Schedule (E-Meeting)
24 February 2021
Management Discussion and Analysis Yearly Ending 31 Dec 2020
24 February 2021
Financial Performance Yearly (F45) (Audited)
24 February 2021
Financial Statement Yearly 2020 (Audited)
21 January 2021
Report on use of proceeds from capital increase raised from IPO
10 November 2020
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2020
10 November 2020
Financial Performance Quarter 3 (F45) (Reviewed)